Balloon dilatation of the prostatic urethra is safe and maybe an effective short-term alternative to transurethral resection in patients with small benign prostates. It has no role in the treatment of urinary retention. Subjective improvement may occur in up to 70% of men, but longterm objective benefit as shown by urodynamic assessment does not occur.Benign prostatic hyperplasia (BPH) is a pathological term used to describe the histological features present in the prostate of most men over the age of 60. Symptoms often associated with this condition are those ascribed to bladder outflow obstruction (BOO), e.g. hesitancy and poor urine stream and those of detrusor irritability, e.g. diurnal frequency and urgency. The exact mechanism that results in BOO or detrusor irritability is unknown. However, the facility with which urologists are able to justify removal of the prostate or bladder neck based on a clinical diagnosis of BPH and almost any urinary symptom has led a number of workers to evaluate the role of surgery to the prostate and its current position in some urological centres as a panacea for any urinary symptoms associated with BPH [19]. Symptoms were the determining indication for a transurethral resection of the prostate in 90.7% of cases [17]. In a poll of 89 urologists it was found that the elicitation of a history of symptoms (98 %) was the most common mandatory procedure prior to surgery, with a urine flow rate recorded in only 8% of cases [12].There is no totally satisfactory definition of bladder outflow obstruction, a condition for which a transurethral resection or bladder neck incision would be indicated, but when patients with urinary symptoms are not fully evaluated by urodynamic studies and like is not compared with like, it is hardly surprising that 27% of men on hospital waiting lists for transurethral resection of the prostate were found not to have obstruction according to urodynamic criteria, so that they should not require operations [15]. Because of the failure to make an accurate diagnosis of the condition causing the symptoms, only 80% of men have a satisfactory symptomatic result following transurethral resection. It is not surprising that non-urologists are questioning the role of surgery for urinary symptoms in elderly men, in view of the operation's mortality, morbidity and re-operation rate [17,19]. In a condition where symptoms may wax and wane, a full assessment of any therapy, to avoid any placebo effect, requires randomised controlled clinical trials comparing like with like [8]. Because of lacking objectivity in assessing the role of a transurethral resection, we are now seeing many new, less invasive therapies, e.g. alpha blockade, insertion of prostatic stents and spirals, hyperthermia and balloon dilatation. This has led to an exponential expansion of the scientific literature, with reports of small series of patients, short-term follow-up, subjective assessment and comparison of patient groups that are not strictly comparable.